FDA investigates possible Vytorin link to cancer

August 23, 2008

(AP) -- Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.

---

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

---

Similar stories from PHYSorg:

Trials find no benefits of Zetia

Jan 15, 2008 | 3.6 / 5 (12) | 0

FDA questions safety of Glaxo kidney cancer drug

Oct 01, 2009 | not rated yet | 0

FDA: Arthritis drugs pose cancer risk to children

Aug 04, 2009 | not rated yet | 1

Anti-psychotic drugs could help fight cancer

Aug 12, 2009 | 4.8 / 5 (4) | 1

FDA won't accept Merck's application for new drug

Nov 02, 2009 | 3 / 5 (1) | 0

• JerryPark - Aug 23, 2008
  • Rank: 5 / 5 (1)
  Statins have been suspected of causing cancer for years. No one has really tried to determine if there is an association with increased cancer because such a link would likely result in decreased sales of statins.
  
  The known problems with statin therapy and the severe disability, organ failure and deaths they cause should be sufficient to limit sales, but they apparently do not limit sales.
  
  Of course, the advice in the article is to keep taking statins.
  • report abuse
  • • Current rank
    • 1
    • 2
    • 3
    • 4
    • 5